Peer-influenced content. Sources you trust. No registration required. This is HCN.
Psychiatrist.com
The objective of the study was to characterize the real-world safety profile of TMS devices based on MAUDE-reported AEs, including symptom patterns, manufacturer-level variations, device issues, and reporting delays.
Psychiatry March 4th 2026
Psych Congress Network
“TRD patients have extremely limited treatment options, and the unmet need remains profound.” — Guy Goodwin, MD, CMO, Compass Pathways
“Evenamide has the potential to treat the symptoms of schizophrenia more broadly, addressing also those poorly managed by the currently available antipsychotics.” — Ravi Anand, MD, Therapeutic Advances in Psychopharmacology
Psychiatry February 18th 2026
Cleveland Clinic Journal of Medicine (CCJM)
Deprescribing benzodiazepines in patients on long-term stable treatment led to increased mortality along with increases in nonfatal overdoses, suicidal ideation, and emergency department visits.
Psychiatry January 21st 2026
MedCentral
“These drugs are not weight loss drugs. “These are not diabetes drugs. These are drugs that have multiple purposes, including obesity and diabetes, and possibly they might even help protect the brain.” – Roger McIntyre, MD
Endocrinology, Diabetes, Metabolism January 21st 2026
Pharmacy Learning Network
“Pharmacies exist to heal the sick, not to fuel addiction and line the pockets of drug traffickers.” – DEA Administrator Terrance Cole
Clinical Pharmacology December 11th 2025